Menu
Menu
On February 24, 2010, the Food and Drug Administration (FDA) posted updated information regarding the availability of propofol on its website.
In summary, APP, one of the manufacturers of propofol, is launching an FDA approved generic version of propofol (10 mg/ml injection) that should help alleviate the shortages. With the availability of this new product, importation and distribution of Propoven 1% (propofol 1%) from APP will be suspended. Meanwhile, the other two other manufacturers, Teva and Hospira, are back online and are working to restore availability to meet market demand.
For complete details of this announcement, please visit the FDA’s website
ASA will continue to work closely with the FDA to ensure that necessary anesthesia drugs remain readily available. If you or your facility are experiencing difficulty obtaining any drug, please contact the FDA’s drug shortage group at [email protected].
